This update was too big for just one slide! Michael Turk produced two Visual Primers to help you understand the 2021 GN changes at-a-glance.
Summary of the CAPTIVATE platform which will be a twitter spaces discussion
This week, we will discuss a registry trial: can a nationwide nudge fix a CKD treatment gap?
This week, we will discuss a pediatric nephrology trial: is tacrolimus superior to MMF in FRNS and SDNS?
This week, we will discuss a NEJM trial on uncontrolled hypertension: lorundrostat, an aldosterone synthase inhibitor, aims at the hormonal dark side driving resistance.
This update was too big for just one slide! Michael Turk produced two Visual Primers to help you understand the 2021 GN changes at-a-glance.